Rechercher un essai clinique
Autre(s) option(s) de recherche
11 Résultat(s)
Essai en cours de recrutement = 
; Essai en cours = 
; Financé par un membre IRDiRC = 
; Membre d'un ERN = 
Essai(s) clinique(s) national(aux)
ALLEMAGNE
Baden-Württemberg
ULM
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitäts- und Rehabilitationskliniken Ulm (RKU)
Klinik für Neurologie
ALLEMAGNE
Bayern
MÜNCHEN
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
LMU Klinikum der Universität München - Campus Großhadern
Institut für Klinische Neuroimmunologie
ALLEMAGNE
Bayern
WÜRZBURG
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Neurologische Klinik und Poliklinik des Universitätsklinikums Würzburg
Neurologische Klinik und Poliklinik
ALLEMAGNE
Berlin
BERLIN
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Charité - Universitätsmedizin Berlin (CCM)
Klinik für Neurologie (CCM)
ALLEMAGNE
Niedersachsen
HANNOVER
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Medizinische Hochschule Hannover
Abteilung Klinische Neuroimmunologie und Neurochemie
ALLEMAGNE
Nordrhein-Westfalen
BOCHUM
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Neurologisches Universtätsklinikum im St. Josef-Hospital
Klinik für Neurologie
ALLEMAGNE
Nordrhein-Westfalen
MÜNSTER
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsklinikum Münster
Klinik für Neurologie mit Institut für Translationale Neurologie
ALLEMAGNE
Rheinland-Pfalz
MAINZ
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsmedizin Mainz
Klinik und Poliklinik für Neurologie
ALLEMAGNE
Schleswig-Holstein
KIEL
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Klinik für Neurologie
ALLEMAGNE
Thüringen
JENA
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsklinikum Jena
Hans-Berger-Klinik für Neurologie
ROYAUME-UNI
Oxfordshire
OXFORD